118 related articles for article (PubMed ID: 27191194)
1. Functional characterization of the ABCG2 5' non-coding exon variants: Stem cell specificity, translation efficiency and the influence of drug selection.
Sándor S; Jordanidisz T; Schamberger A; Várady G; Erdei Z; Apáti Á; Sarkadi B; Orbán TI
Biochim Biophys Acta; 2016 Jul; 1859(7):943-51. PubMed ID: 27191194
[TBL] [Abstract][Full Text] [Related]
2. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
[TBL] [Abstract][Full Text] [Related]
3. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters.
Zong Y; Zhou S; Fatima S; Sorrentino BP
J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162
[TBL] [Abstract][Full Text] [Related]
4. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells.
Apáti A; Orbán TI; Varga N; Németh A; Schamberger A; Krizsik V; Erdélyi-Belle B; Homolya L; Várady G; Padányi R; Karászi E; Kemna EW; Német K; Sarkadi B
Biochim Biophys Acta; 2008 Dec; 1778(12):2700-9. PubMed ID: 18793608
[TBL] [Abstract][Full Text] [Related]
5. Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.
Xie Y; Natarajan K; Bauer KS; Nakanishi T; Beck WT; Moreci RS; Jeyasuria P; Hussain A; Ross DD
Biochim Biophys Acta; 2013 Dec; 1829(12):1288-99. PubMed ID: 24189494
[TBL] [Abstract][Full Text] [Related]
6. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
7. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
10. [Advance of research on relationship between ABCG2 and drug resistance in hematologic malignancies - review].
Qu SQ; Fu ZZ; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):513-8. PubMed ID: 19379601
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.
Nakagawa H; Tamura A; Wakabayashi K; Hoshijima K; Komada M; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
Biochem J; 2008 May; 411(3):623-31. PubMed ID: 18237272
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2.
Zhang JT
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):531-41. PubMed ID: 17767037
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 -- a transporter for all seasons.
Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A
FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
15. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland.
Wu AM; Yang M; Dalvi P; Turinsky AL; Wang W; Butcher D; Egan SE; Weksberg R; Harper PA; Ito S
Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E596-610. PubMed ID: 25117410
[TBL] [Abstract][Full Text] [Related]
17. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
18. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic importance of ABCG2.
Cusatis G; Sparreboom A
Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776
[TBL] [Abstract][Full Text] [Related]
20. A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.
Mitomo H; Kato R; Ito A; Kasamatsu S; Ikegami Y; Kii I; Kudo A; Kobatake E; Sumino Y; Ishikawa T
Biochem J; 2003 Aug; 373(Pt 3):767-74. PubMed ID: 12741957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
